Study Purpose:
Venous thrombo-embolic (VTE) rates could be high in patients with amyotrophic lateral sclerosis (ALS). Indeed, the rate of VTE in this specific population could be 7-fold higher in this population. Predictiv factors of VTE in patients with ALS are mobility reduction and neurological paralysis. However, to our knowledge, medical littérature is poor concerning VTE and ALS association.Our first aim is to define annual rate of VTE in ALS population.Then we aim to identify predictiv factors of VTE in this specific population. The studied population is Brest universitary hospital cohort of ALS patient included between 2000 and 2019.
Study Status:
Not recruiting
Disease:
Lateral Amyotrophic Sclerosis , Venous Thrombo-embolic Desease
Study Type:
Observational
Type of Intervention:
N/A
Intervention Name:
N/A
Placebo:
N/A
Phase:
N/A
Study Chair(s)/Principal Investigator(s):
N/A
Clinicaltrials.gov ID:
Neals Affiliated?
No
Coordinating Center Contact Information
Study Sponsor:
University Hospital, Brest
Estimated Enrollment:
227
Estimated Study Start Date:
03 / 01 / 2020
Estimated Study Completion Date:
05 / 01 / 2020
Posting Last Modified Date:
09 / 11 / 2020
Date Study Added to neals.org:
06 / 24 / 2020
Minimum Age:
N/A
Maximum Age:
N/A
Inclusion Criteria:- patients with amyotrophic lateral sclerosis defined by revised El Escorial score criteria followed in competence centre of Brest Universitary Hospital during 2000 to 2019
Exclusion Criteria:
- no consent
- other neuro-degenerativ diseases
CHRU de Brest
Brest 29200
France